Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Dov Taieb"'
Autor:
Quentin Moyon, Marc Pineton de Chambrun, Marie Gousseff, Alexis Mathian, Miguel Hie, Geoffrey Urbanski, Franco Verlicchi, Stanislas Faguer, Antoine Dossier, Jean-Christophe Lega, Sophie Riviere, David Saadoun, Julie Graveleau, Marie-Josée Lucchini-Lecomte, Christine Christides, Sylvie Le Moal, Béatrice Bibes, Giuseppe Malizia, Marc Ruivard, Gilles Blaison, Laurent Alric, Christian Agard, Martin Soubrier, Jean-François Viallard, Hervé Levesque, Georges-Etienne Rivard, Nathalie Tieulie, Arnaud Hot, Pierre-Yves Lovey, Thomas Hanslik, François Lhote, Vincent Eble, Jorge Álvarez Troncoso, Avinash Aujayeb, Paul Quentric, Dov Taieb, Fleur Cohen-Aubart, Marc Lambert, Zahir Amoura
Publikováno v:
Journal of Allergy and Clinical Immunology: In Practice
Journal of Allergy and Clinical Immunology: In Practice, 2022, 10 (11), pp.2889-2895. ⟨10.1016/j.jaip.2022.07.006⟩
Journal of Allergy and Clinical Immunology: In Practice, 2022, 10 (11), pp.2889-2895. ⟨10.1016/j.jaip.2022.07.006⟩
International audience; Background: The systemic capillary leak syndrome (SCLS), also known as Clarkson disease, is a very rare condition characterized by recurrent life-threatening episodes of vascular hyperpermeability in the presence of a monoclon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff37f7eee45f0767c8bd973b3e66e933
https://hal.science/hal-03888981
https://hal.science/hal-03888981
Autor:
Julien Haroche, Grégory Pugnet, Isabella Annesi-Maesano, Nathalie Freymond, Robin Dhote, Fleur Cohen-Aubart, Hilario Nunes, Nathalie Saindenberg, Aurélien Justet, Nicolas Belhomme, Yurdagul Uzunhan, Abdellatif Tazi, P. Gazengel, Alexis Mathian, Florence Jeny, Raphael Lhote, Stéphane Jouneau, Baptiste Hervier, Yacine Tandjaoui-Lambiotte, Emmanuel Bergot, Dominique Valeyre, Arsène Mekinian, Raphael Borie, Zahir Amoura, Gwenaël Lorillon, Jérôme Le Pavec, Miguel Hie, T. Chazal, Dov Taieb
Publikováno v:
Annals of the Rheumatic Diseases
Patients with interstitial lung disease have been considered at high risk of complications of COVID-19 because of their underlying lung disease and use of immunosuppressive agents.1 However, data on COVID-19 in patients with sarcoidosis are scarce.2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::702d9f71389defb1ed38a3a7ac73516a
https://pubmed.ncbi.nlm.nih.gov/33004332
https://pubmed.ncbi.nlm.nih.gov/33004332
Autor:
Matthias Papo, Jérôme Razanamahéry, Malik Da Silva, Zofia Hélias-Rodzewicz, Vsevolod Potapenko, Suzanna Bota, Vanessa Leguy-Seguin, Stéphane Dominique, Raphaël Lhote, Quentin Moyon, Dov Taïeb, Tom Abrassart, Marion Campana, Visal Keo, Etienne Rivière, Olivier Lucidarme, Fleur Cohen-Aubart, Zahir Amoura, Julien Haroche, Jean-François Emile
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/8495387cbd974e4980631efe53fbe774